Impact of beta-blocker nebivolol versus carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with reduced LVEF treated with drug-eluting stents

31 August 2025 (09:15 - 10:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Soohyung Park

Korea University Guro Hospital, Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail

Aspirin does not reduce cardiovascular risk in smokers across coronary calcium scores after coronary computed tomography angiography

Mr G. Winther (Aalborg, DK)

Abstract Slides Video

Presentation thumbnail

Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy presenting with ACS - a systematic review and meta-analysis

Doctor B. Hakkeem (Kozhikode, IN)

Abstract Slides Video

Presentation thumbnail

Safety and effectiveness of tegoprazan in patients treated with dual antiplatelet therapy after drug-eluting stent implantation for acute myocardial infarction.

Doctor O. Lee (Yongin, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Pharmacotherapy in acute coronary syndromes (4)

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET

You may be interested in

Congress Presentation

Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Congress Presentation

Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Congress Presentation

Impact of 2nd-generation versus 3rd-generation beta-blockers on long-term clinical outcomes in STEMI patients treated with drug-eluting stents

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources